Skip to main content

Advertisement

Log in

Metabolomic study in plasma, liver and kidney of mice exposed to inorganic arsenic based on mass spectrometry

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

The mechanism of arsenic toxicity still remains unclear, although enzymatic inhibition, impaired antioxidants metabolism and oxidative stress may play a role. The toxicological effects of trivalent inorganic arsenic on laboratory mouse Mus musculus after oral administration (3 mg/kg body weight/day) were investigated along 12 days, using a metabolomic approach based on direct infusion mass spectrometry to polar and lipophilic extracts from different organs and fluids (liver, kidney, and plasma). Positive and negative acquisition modes (ESI+/ESI) were used throughout the experiments. The most significant endogenous metabolites affected by exposure were traced by partial least square-discriminant analysis and confirmed by tandem mass spectrometry (MS/MS) and gas chromatography coupled to MS. In this work, the toxic effect of arsenic has been related with important metabolic pathways, such as energy metabolism (e.g., glycolysis, Krebs cycle), amino acids metabolism, choline metabolism, methionine cycle, and degradation of membrane phospholipids (cell apoptosis). In addition, this work illustrates the high reliability of mass spectrometry based on a metabolomic approach to study the biochemical effects induced by metal exposure.

Metabolomic study in plasma, liver and kidney of mice exposed to inorganic arsenic based on mass spectrometry

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig 3
Fig 4
Fig 5
Fig 6
Fig 7

Similar content being viewed by others

References

  1. Vahter M (1999) Methylation of inorganic arsenic in different mammalian species and population groups. Sci Progress 82:69–88

    Google Scholar 

  2. Hirano S, Cui X, Li S, Kanno S, Kobayashi Y, Hayakawa T, Shraim A (2003) Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch Toxicol 77:305–312. http://www.ncbi.nlm.nih.gov/pubmed/12799770

    Google Scholar 

  3. Geiszinger AE, Goessler W, Francesconi KA (2002) Identification of the new arsenic-containing betaine, trimethylarsoniopropionate, in tissues of a stranded sperm whale Physeter catodon. Marine Environ Res 53:37–50

    Google Scholar 

  4. Fattorini D, Regoli F (2004) Arsenic speciation in tissues of the mediterranean polychaete Sabella spallanzanii. Environ Toxicol Chem 23:1881–1887

    Google Scholar 

  5. Fattorini D, Notti A, Regoli F (2006) Characterization of arsenic content in marine organisms from temperate, tropical, and polar environments. Chem Ecol 22:405–414

    Google Scholar 

  6. Wnek SM, Jensen TJ, Severson PL, Futscher BW, Gandolfi AJ (2010) Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. Toxicol Sci 116:44–57

    Google Scholar 

  7. Naranmandura H, Ogra Y, Iwata K, Lee J, Suzuki KT, Weinfeld M, Le XC (2009) Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells. Toxicol Appl Pharmacol 238:133–140

    Google Scholar 

  8. Hirata S, Toshimitsu H, Aihara M (2006) Determination of arsenic species in marine samples by. HPLC-ICP-MS. Anal Sci 22:39–43

    Google Scholar 

  9. Petrick JS, Jagadish B, Mash EA, Aposhian HV (2001) Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Chem Res Toxicol 14:651–656

    Google Scholar 

  10. Thomas DH, Li J, Waters SB, Xing W, Adair BD, Drobna Z, Devesa V, Styblo M (2007) Arsenic (+3 oxidation state) methyltransferase and methylation of arsenicals. Exp Biol Med 232:3–13

    Google Scholar 

  11. Aposhian HV, Aposhian MM (2006) Arsenic toxicology: five questions. Chem Res Toxicol 19:1–15

    Google Scholar 

  12. Menzel DB, Hamadeh HK, Lee E et al (1999) Arsenic binding proteins from human lymphoblastoid cells. Toxicol Lett 105:89–101

    Google Scholar 

  13. Winski SL, Carter DE (1995) Interactions or rat red blood cell sulfhydryls with arsenate and arsenite. J Toxicol Environ Health 46:379–397

    Google Scholar 

  14. Lu M, Wang H, Li XF et al (2004) Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood. Chem Res Toxicol 17:1733–1742

    Google Scholar 

  15. Ngu TT, Stillman MJ (2006) Arsenic binding to human metallothionein. J Am Chem Soc 128:12473–12483

    Google Scholar 

  16. Chang KN, Lee TC, Tam MF, Chen YC, Lee LW, Lee SY, Lin PJ, Huang NR (2003) Identification of galectin I and thioredoxin peroxidase II as two arsenic-binding proteins in Chinese hamster ovary cells. J Biochem 371:495–503

    Google Scholar 

  17. Kitchin KT (2001) Identification of galectin I and thioredoxin peroxidase II as two arsenic-binding proteins in Chinese hamster ovary cells. Toxicol Appl Pharm 172:249–261

    Google Scholar 

  18. Kitchin KT, Wallace K (2008) The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. J Inorg Biochem 102:532–539

    Google Scholar 

  19. Gailer J, Ruprecht L, Reitmeir P, Benker B, Schramel P (2004) Mobilization of exogenous and endogenous selenium to bile after the intravenous administration of environmentally relevant doses of arsenite to rabbits. Appl Organomet Chem 18:670–675

    Google Scholar 

  20. Carew MW, Leslie EM (2010) Selenium-dependent and Independent Transport of Arsenic by the Human Multidrug Resistance Protein 2 (MRP2/ABCC2): Implications for the Mutual Detoxification of Arsenic and Selenium. Carcinogenesis 31:1450–1455

    Google Scholar 

  21. Hughes MF, Kenyon EM, Edwards BC, Mitchell CT, Del Razo LM, Thomas DJ (2003) Accumulation and metabolism of arsenic in mice after repeated administration of arsenate. Toxicol Appl Pharmacol 191:202–210

    Google Scholar 

  22. Carlson-Lynch H, Beck BD, Boardman PD (1994) Arsenic risk assessment. Environ Health Perspect 102:354–356

    Google Scholar 

  23. García-Chávez E, Santamaría A, Díaz-Barriga F, Mandeville P, Juárez BI, Jiménez-Capdeville ME (2003) Arsenite-induced formation of hydroxyl radical in the striatum of awake rats. Brain Res 976:82–89

    Google Scholar 

  24. Piao F, Ma N, Hiraku Y, Murata M, Oikawa S, Cheng F, Zhong L, Yamauchi T, Kawanishi S, Yokoyama K (2003) Oxidative DNA damage in relation to neurotoxicity in the brain of mice exposed to arsenic at environmentally relevant levels. J Occup Health 47:445–449

    Google Scholar 

  25. Brown KG, Boyle KE, Chen CW, Gibb HJ (1989) A dose-response analysis of skin cancer from inorganic arsenic in drinking water. Risk Anal 9:519–528

    Google Scholar 

  26. Chen CJ, Chuang YC, You SL, Lin TM, Wu HY (1986) A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 53:399–405

    Google Scholar 

  27. Warner ML, Moore LE, Smith MT, Kalman DA, Fanning E, Smith AH (1994) Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol Biomarkers Prev 3:583–590

    Google Scholar 

  28. Szymanska-Chabowska A, AntonowiczJuchniewicz J, Andrzejak R (2007) The concentration of selected cancer markers (TPA, TPS, CYFRA 21-1, CEA) in workers occupationally exposed to arsenic (As) and some heavy metals (Pb, Cd) during a two-year observation study. Int J Occup Med Environ Health 20:229–239

    Google Scholar 

  29. Bowen BP, Northen TR (2010) Dealing with the unknown: metabolomics and metabolite atlases. J Am Soc Mass Spectrom 21:1471–1476

    Google Scholar 

  30. Fiehn O (2002) Metabolomics – the link between genotypes and phenotypes. Plant Mol Biol 48:155–171

    Google Scholar 

  31. Beger RD, Sun J, Schnackenberg LK (2010) Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol 243:154–166

    Google Scholar 

  32. Nicholson JK, Lindon JC, Holmes E (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189

    Google Scholar 

  33. Wei L, Liao P, Wu H, Li X, Pei F, Li W, Wu Y (2009) Metabolic profiling studies on thetoxicological effects of realgar in rats by (1)H NMR spectroscopy. Toxicol Appl Pharmacol 234:314–325

    Google Scholar 

  34. García-Sevillano MA, Jara-Biedma R, González-Fernández M, García-Barrera T, Gómez-Ariza JL (2013) Metal interactions in mice under environmental stress. Biometals 5:855–860

    Google Scholar 

  35. Dunn WB (2008) Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes. Phys Biol 5:1–11

    Google Scholar 

  36. Griffin JL, Blenkiron C, Valonen PK, Caldas C, Kauppinen RA (2006) High-Resolution Magic Angle Spinning (1)H NMR Spectroscopy and Reverse Transcription-PCR. Anal Chem 78:1546–1552

    Google Scholar 

  37. Lin L, Yu Q, Yan X, Hang W, Zheng J, Xing J, Huanga B (2010) Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer. Analyst 135:2970

    Google Scholar 

  38. González-Domínguez R, García-Barrera T, Gómez-Ariza JL (2012) Metabolomic approach to Alzheimer’s disease diagnosis based on mass spectrometry. Chem Papers 66:829–835

    Google Scholar 

  39. Sun G, Yang K, Zhao Z, Guan S, Han X, Gross RW (2007) Shotgun metabolomics approach for the analysis of negatively charged water-soluble cellular metabolites from mouse heart tissue. Anal Chem 79:6629–6640

    Google Scholar 

  40. Favretto D, Cosmi E, Ragazzi E, Visentin S, Tucci M, Fais P, Cecchetto G, Zanardo V, Viel G, Ferrara SD (2012) Cord blood metabolomic profiling in intrauterine growth restriction. Anal Bioanal Chem 402:1109–1121

    Google Scholar 

  41. Lin L, Yu Q, Yan X, Hang W, Zheng J, Xing J, Huang B (2010) A serum metabonomic study of kidney cancer. Analyst 135:2970–2978

    Google Scholar 

  42. Watson AD (2006) Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res 47:2101–2111

    Google Scholar 

  43. Sun G, Yang K, Zhao Z, Guan S, Han X, Gross RW (2007) Shotgun metabolomics approach for the analysis of negatively charged water-soluble cellular metabolites from mouse heart tissue. Anal Chem 79:6629–6640

    Google Scholar 

  44. Jiye A, Trygg J, Gullberg J, Johansson AI, Jonsson P, Antti H, Marklund SL, Moritz T (2005) Extraction and GC/MS Analysis of the Human Blood. Plasma Metabolome. Anal Chem 77:8086–8094

  45. Pérez-Enciso M, Tenenhaus M (2003) Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Human Genetics 112:581–592

    Google Scholar 

  46. Reichl FX, Szinicz L, Kreppel H, Forth W (1988) Effect of arsenic on carbohydrate metabolism after single or repeated injection in guinea pigs. Arch Toxicol 62:473–475

    Google Scholar 

  47. Reichl FX, Szinicz L, Kreppel H, Fichtl B, Forth W (1990) Effect of glucose in mice after acute experimental poisoning with arsenic trioxide (As2O3). Arch Toxicol 64:336–338

    Google Scholar 

  48. Szinicz W (1988) Effect of As2O3 on gluconeogenesis. Forth Arch Toxicol 61:444–449

    Google Scholar 

  49. Connor SC, Wu W, Sweatman BC, Manini J, Haselden JN, Crowther DJ, Waterfield DJ (2004) Effects of feeding and body weight loss on the 1H-NMR-based urine metabolic profiles of male Wistar Han Rats: Implications for biomarker discovery. Biomarkers 9:156–179

    Google Scholar 

  50. Dasgupta T, Hebbel RP, Kaul DK (2006) Protective effect of arginine on oxidative stress in transgenic sickle mouse models. Free Radical Biol Med 41:1771–1780

    Google Scholar 

  51. Watanabe S, Togashi S, Takahashi N, Fukui T (2002) L-Tryptophan as an antioxidant in human placenta extract. J Nutr Sci Vitaminol 48:36–39

    Google Scholar 

  52. Jin Y, Zhao F, Zhong Y, Yu X, Sun D, Liao Y, Lv X, Li G, Sun G (2010) Effects of exogenous GSH and methionine on methylation of inorganic arsenic in mice exposed to arsenite through drinking water. Environ Toxicol 25:361–366

    Google Scholar 

  53. Stýblo M, Thomas DJ (1995) In vitro inhibition of glutathione reductase by arsenotriglutathione. Biochem Pharmacol 49:971–977

    Google Scholar 

  54. Thomas DJ, Styblo M, Lin S (2001) The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 176:127–144

    Google Scholar 

  55. Griffin JL, Mann CJ, Scott J, Shoulders CC, Nicholson JK (2001) Choline containing metabolites during cell transfection: an insight into magnetic resonance spectroscopy detectable changes. FEBS Lett 509:263–266

    Google Scholar 

  56. Skipski VP et al (1967) Lipid composition of human serum lipoproteins. Biochem J 104:340–352

    Google Scholar 

  57. Koivusalo M, Haimi P, Heikinheimo L, Kostiainen R, Somerharaju P (2001) Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response. J Lipid Res 42:663–672

    Google Scholar 

  58. Bashir S, Harma Y, Irshad M, Gupta SD, Dogra TD (2006) Arsenic-induced cell death in liver and brain of experimental rats. Basic Clin Pharmacol Toxicol 98:38–43

    Google Scholar 

  59. Zacarias A, Bolanowski D, Bhatnagar A (2002) Comparative measurements of multicomponent phospholipid mixtures by electrospray mass spectroscopy: relating ion intensity to concentration. Anal Biochem 308:152–159

    Google Scholar 

  60. Gürer H, Ozgünes H, Saygin E, Ercal E (2001) Antioxidant Effect of Taurine Against Lead-Induced Oxidative Stress. Arch Environ Cont Toxicol 41:397–402

    Google Scholar 

  61. Sinha M, Manna P, Sil PC (2008) Taurine protects antioxidant defense system in the erythrocytes of cadmium treated mice. BMB Reports 41:657–663

    Google Scholar 

  62. Griffin JL, Walker LA, Shore RF, Nicholson JK (2001) High-resolution magic angle spinning 1H-NMR spectroscopy studies on the renal biochemistry in the bank vole (Clethrionomys glareolus) and the effects of arsenic (As3+) toxicity. Xenobiotica 31:377–385

    Google Scholar 

  63. Griffin JL, Walker LA, Shore RF, Nicholson JK (2001) Metabolic profiling of chronic Cadmium exposure in the rat. Chem Res Toxicol 14:1428–1434

    Google Scholar 

  64. Engelmann J, Henke J, Willker W, Kutscher B, Nossner G, Engel J, Leibfritz D (1996) Early stage monitoring of miltefo- sien induced apoptosis in KB cells by mulktinuclear NMR. Anticancer Res 16:1429–1439

    Google Scholar 

  65. World Health Organization (2001) Arsenic and arsenic compounds. WHO, Geneva

  66. States JC, Srivastava S, Chen Y, Barchowsky A (2009) Arsenic and Cardiovascular Disease. Toxicol Sci 107:312–323

    Google Scholar 

  67. Ardan T, Kovaceva J, Cejková J (2004) Comparative histochemical and immunohistochemical study on xanthine oxidoreductase/xanthine oxidase in mammalian corneal epithelium. Acta Histochem 106:69–75

    Google Scholar 

  68. Harrison R (2002) Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 33:774–797

    Google Scholar 

  69. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11:4145–4151

    Google Scholar 

  70. Becker BF (1993) Towards the physiological function of uric acid. Free Radical Biol Med 14:615–631

    Google Scholar 

Download references

Acknowledgments

This work was supported by the project CTM2012-38720-C03-01 from the Spanish Ministry of Economy and Competitiveness, and by projects P08-FQM-3554, P09-FQM-4659, P08-CVI-03829, and P08-RNM-00523 from the Regional Ministry of Economy, Innovation, Science and Employment (Andalusian Government, Spain). M.A. García Sevillano thanks the Spanish Ministry of Education for a PhD scholarship.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to T. García-Barrera or J. L. Gómez-Ariza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

García-Sevillano, M.A., Contreras-Acuña, M., García-Barrera, T. et al. Metabolomic study in plasma, liver and kidney of mice exposed to inorganic arsenic based on mass spectrometry. Anal Bioanal Chem 406, 1455–1469 (2014). https://doi.org/10.1007/s00216-013-7564-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-013-7564-z

Keywords

Navigation